REVA PHARMA, is a fully integrated Healthcare and Pharmaceutical organization. Licensing, Product Development, Contract Manufacturing and Healthcare Services form the main activities of the company. Its operations and initiatives are backed up by regulatory approved infrastructure, which help to offer its partners, Products & Services complying with cGMP, GLP & EHS standards. It has carved out a name for itself in the Healthcare space across geographies for Reliability, Transparency and Trust.

Since incorporation in 2009, it has moved up in the industry ranking, with emphasis on its operations in Regulated, Expanding and Emerging markets. We have fulfilled our promise of providing value added products and services to our clients with rewarding partnerships.

National Healthcare Leadership Congress & Awards

Dr Gurpreet Sandhu, CEO and founder of Reva Pharma receiving Pharma Leadership Award endorsed by the World Federation of Healthcare Professionals on 28th September 2019 at the Taj Mahal Hotel, New Delhi.

OUR PUBLISHED ARTICLES


India’s health diplomacy during a global pandemic and the Future of Pharma

Article Name: 'India’s health diplomacy during a global pandemic and the Future of Pharma'
Updated on: 4th AUG 2020
Published On: BusinessWorld

Since COVID, Biowaste Has Increased By 300 Per Cent

Article Name: 'Since COVID, Biowaste Has Increased By 300 Per Cent'
Updated on: Jul 19, 2020, 20:40 IST
Published By: Anju Maskeri

Making India self-sufficient, Dr Gurpreet Sandhu

Article Name: 'Making India self-sufficient'
Updated on: Aug 28, 2020
Published On: Express Pharma

Remdesivir can put India centre stage once again during the Covid-19...

Article Name: 'Remdesivir can put India centre stage once again during the Covid-19 pandemic'
Updated on: Aug 31, 2020
Published On: Times of India

Covid-19 Restrictions Boost India’s Online Pharmacy Sector

Article Name: Covid-19 Restrictions Boost India’s Online Pharmacy Sector
Updated on: Sep 6, 2020
Published By: Rebecca Bundhun, The National

Council For Healthcare And Pharma To Focus On Regulatory Reforms Issues

Article Name: Council For Healthcare And Pharma To Focus On Regulatory Reforms Issues
Updated on: Sep 8, 2020
Published By: Yash Ved, Pharmabiz

Addressing Nitrosamine And Related Impurities In Pharmaceuticals

Article Name: Addressing Nitrosamine And Related Impurities In Pharmaceuticals
Published on: Sep 25, 2020
Published By: Bio Spectrum, India

Interruption due to the pandemic in the continuum of care for heart patie...

Article Name: Interruption due to the pandemic in the continuum of care for heart patients can lead...
Published on: Sep 25, 2020
Published By: India.com

CHP to offer expert consultative advice for setting up Medical Device and Pharma Parks in UP

Article Name: CHP to offer expert consultative advice for setting up Medical Device and Pharma Parks in UP
Updated on: Oct 3, 2020
Published By: YashVed, PharmaBiz, Mumbai, India

India has 0.75 psychiatrists per 100,000 people. Can telepsychiatry bridge the gap between mental...

OUR MISSION & VISION


"Our Mission is to provide Quality Pharmaceutical products and Healthcare services to our global business partners, ensuring highest standards in manufacturing and laboratory practices as well as compliance to Environment, Health and Safety norms. We are bound by our motto: Caring for Healthier Lives.

Our Vision is to be the permanent partner of choice for the products and services that we offer, by creating environment of Reliability, Transparency and Trust."

MARKETS


Our flagship markets are Japan, USA, Germany, Italy and Korea. We hold partnerships and alliances with Innovators, Biological, and Generic organizations the areas of Licensing, CRAM and API’s.

Research & Development

Research and Development is one of the major pillars on which a successful and customer oriented organization is built. We at Reva Pharma view R&D capabilities as a vital component of its ...

Regulatory Accreditations

REVA operates according to current Good Manufacturing and Laboratory Practice (cGMP and GLP). Our API and FDF manufacturing facilities have received regulatory approval from the following major health authorities.

OUR NEWS LETTERS


Reva Pharma Monthly Newsletters

RECENT NEWS


ALL NEWS

Coronavirus Puts Global Fight Against Tuberculosis at Risk: ...

16 October 2020

Geneva: The novel coronavirus pandemic threatens to reverse progress towards eliminating tuberculosis, until ...

Over Dependence on China for Basic Ingredients to Make Medic...

14 October 2020

Over dependence on one country, China, for basic ingredients required to make medicines is a cause for concern...

As India Identifies 3 Cases of Reinfection, Lancet Study Say...

14 October 2020

A study analysing coronavirus reinfections and what they mean for the future course of action, published in th...